News & Events
At this year's EASD conference in Lisbon, Portugal Novo Nordisk is proud to announce the launch of a new, unique global study, DAWN 2 . The study aims to gain a 360° perspective on life with diabetes. DAWN 2 will engage key stakeholders in finding new ways to enable people with diabetes to live full, healthy lives and be actively involved in managing their own health.
Meet Dr. Mark Peyrot, an internationally recognised professor of sociology from the US who will share his views on the unique prospects of DAWN 2.
Download Teaser Flyer Press (PDF)
